Literature DB >> 8748765

Evaluation of craniospinal system condition using standardized volume-pressure loadings.

Z Czernicki1, J Berdyga, G Stepińska, J Jurkiewicz.   

Abstract

Standardized volume-pressure craniospinal system loadings based on physiological loadings were developed in order to study the CSF outflow route efficiency and to evaluate the intracranial volume-pressure relations. The study was carried out on 10 cats. Standardized abdominal compression was applied in order to produce a central venous pressure increased and subsequently ICP increase to the level of 20 and 30 mmHg for 2 minutes. The abdominal compression test seems to be useful in the CSF outflow route evaluation. The orthostatic changes were studied in control animals and in cats with an epidural balloon. The animal body was evaluated to an angle of 50 degrees and 80 degrees with the head directed upwards and downwards. This test was found suitable for the intracranial volume reserve estimation. Similar application, especially in experimental conditions can be found in the hypercapnia test. PaCO2 concentration was increased by means of respiration with a gas mixture containing 5% CO2. A steady increase of ICP of 9 +/- 1 mmHg was obtained. Vascular dilatation resulted in an intracranial volume loading. The ICP response in subjects with normal CO2 response can be related to the intracranial volume reserve. The studies performed show the usefulness of the standardized volume-pressure loadings. The loadings applied are more physiological than lumbar infusion tests used so far.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748765     DOI: 10.1007/bf01420073

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  11 in total

1.  ICP dependent changes of CSF outflow resistance.

Authors:  K Tychmanowicz; Z Czernicki; G Pawłowski; G Stepińska
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

2.  Body position and cerebrospinal fluid pressure. Part 2: clinical studies on orthostatic pressure and the hydrostatic indifferent point.

Authors:  B Magnaes
Journal:  J Neurosurg       Date:  1976-06       Impact factor: 5.115

3.  Body position and cerebrospinal fluid pressure. Part 1: clinical studies on the effect of rapid postural changes.

Authors:  B Magnaes
Journal:  J Neurosurg       Date:  1976-06       Impact factor: 5.115

4.  [Effects of respiratory physiotherapy on intracranial pressure in neurosurgical patients].

Authors:  E Lepresle; J B Homs; K Abhay; S Waret; E Vernin; E Melon
Journal:  Agressologie       Date:  1988-04

5.  Intracranial pressure responses to alterations in arterial carbon dioxide pressure in patients with head injuries.

Authors:  R L Paul; O Polanco; S Z Turney; T C McAslan; R A Cowley
Journal:  J Neurosurg       Date:  1972-06       Impact factor: 5.115

6.  Effects of altering arterial carbon dioxide pressure on internal carotid blood flow and cerebrospinal fluid pressure in man.

Authors:  T M Hayes; G T Tindall
Journal:  Surg Forum       Date:  1969

7.  [The effect of hyperventilation and tham(-treatment) on intracranial pressure and the electrical activity of the brain in experimental brain oedema (author's transl)].

Authors:  O E Knoblich; M Gaab; J Schupp; K Dietrich; U Fuhrmeister; P Gruss
Journal:  Neurochirurgia (Stuttg)       Date:  1978-07

8.  A fast method of estimating the elastance of the intracranial system.

Authors:  J Szewczykowski; S Sliwka; A Kunicki; P Dytko; J Korsak-Sliwka
Journal:  J Neurosurg       Date:  1977-07       Impact factor: 5.115

9.  Intracranial pressure and cerebrospinal fluid outflow conductance in healthy subjects.

Authors:  M J Albeck; S E Børgesen; F Gjerris; J F Schmidt; P S Sørensen
Journal:  J Neurosurg       Date:  1991-04       Impact factor: 5.115

10.  Pial arteriolar vessel diameter and CO2 reactivity during prolonged hyperventilation in the rabbit.

Authors:  J P Muizelaar; H G van der Poel; Z C Li; H A Kontos; J E Levasseur
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.